Dinutuximab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Dinutuximab

Brand Name:

Unituxin

Strength:

3.5 mg/mL

HCPCS:

NA

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

GD-2

Oral (Y/N):

No

FDA Approval Year:

2015

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use